Featured Publications
Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response
Peters JS, McIvor A, Papadopoulos AO, Masangana T, Gordhan BG, Waja Z, Otwombe K, Letutu M, Kamariza M, Sterling TR, Bertozzi CR, Martinson NA, Kana ...
Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
Resendiz-Galvan JE, Arora PR, Abdelwahab MT, Udwadia ZF, Rodrigues C, Gupta A, Denti P, Ashavaid TF, Tornheim JA. Pharmacokinetic analysis of linezolid for multidrug resistant ...
Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta?
Checkley W. Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta? Am J Respir Crit Care Med. 2023 Feb 1;207(3):242-243. doi: 10.1164/rccm.202210-1936ED. PMID: 36315435; PMCID: PMC9896637.
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
Thompson RR, Nalugwa T, Oyuku D, Tucker A, Nantale M, Nakaweesa A, Musinguzi J, Reza TF, Zimmer AJ, Ferguson O, Turyahabwe S, Joloba M, Cattamanchi ...
Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studies
Mota F, Ruiz-Bedoya CA, Tucker EW, Holt DP, De Jesus P, Lodge MA, Erice C, Chen X, Bahr M, Flavahan K, Kim J, Brosnan MK, ...
Transcriptional Analysis for Tuberculosis in Pregnant Women From the PRegnancy Associated Changes In Tuberculosis Immunology (PRACHITi) Study
Mathad JS, Queiroz ATL, Bhosale R, Alexander M, Naik S, Kulkarni V, Andrade BB, Gupta A. Transcriptional Analysis for Tuberculosis in Pregnant Women From the ...
Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications
Theresa S Ryckman, David W Dowdy , Emily A Kendall
Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB)
SSM Qual Res Health. 2022 Dec;2:100042. Taylor HA, Dowdy DW, Searle AR, Stennett AL, Dukhanin V, Zwerling AA, Merritt MW.
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda
Value Health. 2022 Jun;25(6):924-930. Thompson RR, Kityamuwesi A, Kuan A, Oyuku D, Tucker A, Ferguson O, Kunihira Tinka L, Crowder R, Turyahabwe S, Cattamanchi A, ...
Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach.
Lancet Infect Dis. 2022 Aug 10:S1473-3099(22)00500-X. doi: 10.1016/S1473-3099(22)00500-X. Epub ahead of print. Ryckman T, Robsky K, Cilloni L, Zawedde-Muyanja S, Ananthakrishnan R, Kendall EA, Shrestha ...
Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects
PLoS One. 2022 Sep 26;17(9):e0270816. Gomes I, Dong C, Vandewalle P, Khan A, Creswell J, Dowdy D, Sohn H.
Quantifying Mycobacterium tuberculosis transmission dynamics across global settings: a systematic analysis
Am J Epidemiol. 2022 Oct 13:kwac181. doi: 10.1093/aje/kwac181. Epub ahead of print. Smith J, Cohen T, Dowdy D, Shrestha S, Gandhi NR, Hill AN.
Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses
Value Health. 2022 Oct 29:S1098-3015(22)04688-5. Dowdy DW, Thompson RR, Kityamuwesi A, Crowder R, Cattamanchi A, Katamba A, Sohn H.
Tuberculosis treatment adherence in the era of COVID-19.”
BMC Infect Dis. 2022 Oct 26;22(1):800. doi: 10.1186/s12879-022-07787-4. PMID: 36289485; PMCID: PMC9607764. Lippincott CK, Perry A, Munk E, Maltas G, Shah M.
Tuberculosis Epidemiologic Studies Consortium. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States
Clin Infect Dis. 2022 Nov 14;75(10):1792-1799. doi: 10.1093/cid/ciac248. PMID: 35363249. Holzman SB, Perry A, Saleeb P, Pyan A, Keh C, Salcedo K, Narita M, Ahmed ...
Diagnostic biomarkers for active tuberculosis: progress and challenges
EMBO Mol Med. 2022 Oct 31;e14088. doi: 10.15252/emmm.202114088 Betânia M F Nogueira # 1 2 3, Sonya Krishnan # 4, Beatriz Barreto-Duarte 3 5 6 ...
An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
Front Immunol. 2022 Sep 16;13:972266. doi: 10.3389/fimmu.2022.972266. eCollection 2022. Styliani Karanika 1 2, James T Gordy 3, Pranita Neupane 1 2, Theodoros Karantanos 4, Jennie ...